| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Cost-Effectiveness Analysis of Nivolumab Compared with Ipilimumab for the Treatment of BRAF Wild-Type Advanced Melanoma in Australia
|
Bohensky, Megan A.
|
|
2016
|
19 |
8 |
p. 1009-1015
7 p.
|
artikel
|
| 2 |
A Differential Item Functioning Analysis of the EQ-5D in Cancer
|
Smith, Adam B.
|
|
2016
|
19 |
8 |
p. 1063-1067
5 p.
|
artikel
|
| 3 |
Arbitration Board Setting Reimbursement Amounts for Pharmaceutical Innovations in Germany When Price Negations between Payers and Manufacturers Fail: An Empirical Analysis of 5 Years’ Experience
|
Ludwig, Saskia
|
|
2016
|
19 |
8 |
p. 1016-1025
10 p.
|
artikel
|
| 4 |
Cancer Care Coordinators to Improve Tamoxifen Persistence in Breast Cancer: How Heterogeneity in Baseline Prognosis Impacts on Cost-Effectiveness
|
Nair, Nisha
|
|
2016
|
19 |
8 |
p. 936-944
9 p.
|
artikel
|
| 5 |
Copyright/Subscription
|
|
|
2016
|
19 |
8 |
p. iii-
1 p.
|
artikel
|
| 6 |
Cost-Effectiveness of a National Opportunistic Screening Program for Atrial Fibrillation in Ireland
|
Moran, Patrick S.
|
|
2016
|
19 |
8 |
p. 985-995
11 p.
|
artikel
|
| 7 |
Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States
|
de Boer, Pieter T.
|
|
2016
|
19 |
8 |
p. 964-975
12 p.
|
artikel
|
| 8 |
Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research
|
Woods, Beth
|
|
2016
|
19 |
8 |
p. 929-935
7 p.
|
artikel
|
| 9 |
Economic Evaluations of Multicomponent Disease Management Programs with Markov Models: A Systematic Review
|
Kirsch, Florian
|
|
2016
|
19 |
8 |
p. 1039-1054
16 p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
2016
|
19 |
8 |
p. IFC-
1 p.
|
artikel
|
| 11 |
EQ-5D Scores for Diabetes-Related Comorbidities
|
Sullivan, Patrick W.
|
|
2016
|
19 |
8 |
p. 1002-1008
7 p.
|
artikel
|
| 12 |
Erratum
|
|
|
2016
|
19 |
8 |
p. 1068-
1 p.
|
artikel
|
| 13 |
ERRATUM
|
|
|
2016
|
19 |
8 |
p. 1068-
1 p.
|
artikel
|
| 14 |
ERRATUM
|
|
|
2016
|
19 |
8 |
p. 1068-
1 p.
|
artikel
|
| 15 |
From the Co-Editors-In-Chief
|
|
|
2016
|
19 |
8 |
p. 909-
1 p.
|
artikel
|
| 16 |
Health Economics as Rhetoric: The Limited Impact of Health Economics on Funding Decisions in Four European Countries
|
Franken, Margreet
|
|
2016
|
19 |
8 |
p. 951-956
6 p.
|
artikel
|
| 17 |
How to Get Cost-Effectiveness Analysis Right? The Case of Vaccine Economics in Latin America
|
Glassman, Amanda
|
|
2016
|
19 |
8 |
p. 913-920
8 p.
|
artikel
|
| 18 |
Instructions for Authors
|
|
|
2016
|
19 |
8 |
p. I-IV
nvt p.
|
artikel
|
| 19 |
Life Expectancy and Lifetime Health Care Expenditures for Type 1 Diabetes: A Nationwide Longitudinal Cohort of Incident Cases Followed for 14 Years
|
Ou, Huang-Tz
|
|
2016
|
19 |
8 |
p. 976-984
9 p.
|
artikel
|
| 20 |
Making Choices on the Journey to Universal Health Care Coverage: From Advocacy to Analysis
|
Chalkidou, Kalipso
|
|
2016
|
19 |
8 |
p. 910-912
3 p.
|
artikel
|
| 21 |
Node-Splitting Generalized Linear Mixed Models for Evaluation of Inconsistency in Network Meta-Analysis
|
Yu-Kang, Tu
|
|
2016
|
19 |
8 |
p. 957-963
7 p.
|
artikel
|
| 22 |
Order of Presentation of Dimensions Does Not Systematically Bias Utility Weights from a Discrete Choice Experiment
|
Norman, Richard
|
|
2016
|
19 |
8 |
p. 1033-1038
6 p.
|
artikel
|
| 23 |
Psychometric Properties of the Four-Item Morisky Green Levine Medication Adherence Scale among Atherosclerosis Risk in Communities (ARIC) Study Participants
|
Beyhaghi, Hadi
|
|
2016
|
19 |
8 |
p. 996-1001
6 p.
|
artikel
|
| 24 |
Reviewer Acknowledgement
|
|
|
2016
|
19 |
8 |
p. 1069-1073
5 p.
|
artikel
|
| 25 |
Table of Contents
|
|
|
2016
|
19 |
8 |
p. i-ii
nvt p.
|
artikel
|
| 26 |
The Cost of Costing Treatments Incorrectly: Errors in the Application of Drug Prices in Economic Evaluation Due to Failing to Account for the Distribution of Patient Weight
|
Hatswell, Anthony J.
|
|
2016
|
19 |
8 |
p. 1055-1058
4 p.
|
artikel
|
| 27 |
The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought
|
Wilkinson, Thomas
|
|
2016
|
19 |
8 |
p. 921-928
8 p.
|
artikel
|
| 28 |
Translating Pharmacometrics to a Pharmacoeconomic Model of COPD
|
Slejko, Julia F.
|
|
2016
|
19 |
8 |
p. 1026-1032
7 p.
|
artikel
|
| 29 |
Update to the Report of Nationally Representative Values for the Noninstitutionalized US Adult Population for Five Health-Related Quality-of-Life Scores
|
Hanmer, Janel
|
|
2016
|
19 |
8 |
p. 1059-1062
4 p.
|
artikel
|
| 30 |
Using Patient-Reported Outcomes for Economic Evaluation: Getting the Timing Right
|
Schilling, Chris
|
|
2016
|
19 |
8 |
p. 945-950
6 p.
|
artikel
|
Tijdschrift beschrijving